REGENERON
USPTO Trademark Record · Serial No. 85596884
Trademark details
It was initially claimed by Regeneron Pharmaceuticals, Inc. on 20120413.
That brand applies to the following goods and services:Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders, Research and development of pharmaceutical preparations; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies; Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; Genetic research; Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of, Providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services.
Currently that trademark is represented by trademark attorney(s): Terrence J. McAllister.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the REGENERON trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
